Trials of the treatment, called fitusiran, found it stopped bleeds in up to two-thirds (66 per cent) of patients with haemophillia A or B.
Experts say the preventative treatment could soon improve patients’ daily lives by slashing the number of hospital trips. The Daily Mail
See also:
No comments:
Post a Comment